Nauzene Tablet, Chewable
Product Images NDC 52389-242

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nauzene (NDC 52389-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kobayashi Healthcare International, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nauzenechewables42r4

Nauzene Chewable Tablets, 230 mg sodium citrate dihydrate, packaged in a box containing 42 tablets with wild cherry flavor. The label highlights the product as non-drowsy and doctor recommended, with a 4-minute formula for prompt relief. The labeler is Kobayashi Healthcare International, Inc., distributed by ALVA-AMCO Pharmacal Cos., LLC. The packaging features images of cherries and multiple claims including aspirin-free, salicylate-free, and gluten-free. Active ingredient and drug facts are partially visible on the unfolded side panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.